Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-03

Clinical Trial Update: Liraglutide Hospital Discharge Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for liraglutide in patients with Type 2 diabetes; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Emory University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2021-11-03